- Home
- FPAY vs RLAY Comparison
FPAY vs RLAY Comparison
Compare FPAY & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FPAY
- RLAY
- Stock Information
- Founded
- FPAY 2003
- RLAY 2015
- Country
- FPAY United States
- RLAY United States
- Employees
- FPAY N/A
- RLAY N/A
- Industry
- FPAY Diversified Commercial Services
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FPAY Consumer Discretionary
- RLAY Health Care
- Exchange
- FPAY Nasdaq
- RLAY Nasdaq
- Market Cap
- FPAY 18.3M
- RLAY 803.4M
- IPO Year
- FPAY N/A
- RLAY 2020
- Fundamental
- Price
- FPAY $0.32
- RLAY $6.49
- Analyst Decision
- FPAY Strong Buy
- RLAY Strong Buy
- Analyst Count
- FPAY 2
- RLAY 8
- Target Price
- FPAY $2.25
- RLAY $17.25
- AVG Volume (30 Days)
- FPAY 999.9K
- RLAY 1.7M
- Earning Date
- FPAY 11-12-2025
- RLAY 11-05-2025
- Dividend Yield
- FPAY N/A
- RLAY N/A
- EPS Growth
- FPAY N/A
- RLAY N/A
- EPS
- FPAY N/A
- RLAY N/A
- Revenue
- FPAY $139,800,732.00
- RLAY $8,355,000.00
- Revenue This Year
- FPAY $19.71
- RLAY $27.33
- Revenue Next Year
- FPAY N/A
- RLAY $7.40
- P/E Ratio
- FPAY N/A
- RLAY N/A
- Revenue Growth
- FPAY 19.51
- RLAY N/A
- 52 Week Low
- FPAY $0.27
- RLAY $1.78
- 52 Week High
- FPAY $2.37
- RLAY $7.00
- Technical
- Relative Strength Index (RSI)
- FPAY 28.64
- RLAY 66.70
- Support Level
- FPAY $0.32
- RLAY $5.85
- Resistance Level
- FPAY $0.39
- RLAY $6.79
- Average True Range (ATR)
- FPAY 0.07
- RLAY 0.39
- MACD
- FPAY -0.01
- RLAY 0.03
- Stochastic Oscillator
- FPAY 11.96
- RLAY 66.58
About FPAY FlexShopper Inc.
FlexShopper Inc is a financial technology company engaged in providing certain types of durable goods to consumers on a lease-to-own basis and providing lease-to-own (LTO) terms to consumers of third-party retailers and e-tailers. Its products include electronics, computers, furniture, mattresses, cameras and camcorders, audio, musical instruments, health, fitness and sports, video games, homes, gardens and tools, appliances, and vacuums on a payment, lease basis. The firm generates a majority of its revenue by leasing its products. The company enables consumers utilizing its e-commerce marketplace to shop for brand-name electronics, home furnishings, and other durable goods on a lease-to-own (LTO) basis.
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).